At the ongoing China International Import Expo (CIIE), global medical firms are unveiling hundreds of cutting-edge technologies, signaling a robust commitment to the Chinese market.
Huzur Devletsah, President of Lilly China, described China as a vital and strategic market, bolstered by supportive national policies and new pilot zones in major cities. \"China’s dynamic environment offers immense opportunities for growth and innovation,\" Devletsah stated.
Rick Kozloski, President of Alcon China, emphasized the company's dedication to timely innovations and improving accessibility for Chinese patients. \"Our focus is on delivering advanced solutions that meet the needs of the local population,\" Kozloski said.
Jenny Zheng, General Manager for Greater China at Illumina, highlighted China's scientific advancements and reaffirmed a \"for China, in China\" commitment. Zheng noted that CIIE serves as a crucial platform for global collaboration, fostering partnerships that drive medical breakthroughs.
Reference(s):
cgtn.com
